Department of Cardiac Surgery (N.R.T., G.M.D., H.J.P.), Department of Internal Medicine (K.A.E.), Michigan Cardiovascular Outcomes Research and Reporting Program (D.G.M.), University of Michigan Health System, Ann Arbor, MI; Department of Surgery, St. Michael's Hospital, Toronto, Ontario, Canada (M.D.P.); Department of Surgery, University of Chicago Medical Center, Chicago, IL (M.J.R.); Department of Cardiothoracic Surgery, University of Vienna, Vienna, Austria (M.P.E.); Department of Clinical Medicine, Tromso University Hospital, Tromsø, Norway (T.M.); Department of Surgery, University of Virginia Health System, Charlottesville, VA (G.R.U.); Department of Cardiovascular Surgery, Mayo Clinic, Rochester, MN (K.G.); Department of Surgery, Dartmouth-Hitchcock Medical Center, Lebanon, NH (M.F.); Department of Cardiac Surgery, Hospital Universitario "12 de Octubre," Madrid, Spain (A.F.); Massachusetts General Hospital, Boston, MA (E.M.I.); and Department of Cardiology, University Hospital Eppendorf-Rostock, Rostock, Germany (C.A.N.).
Circulation. 2013 Sep 10;128(11 Suppl 1):S180-5. doi: 10.1161/CIRCULATIONAHA.112.000342.
Prior cardiac surgery (PCS) can complicate the presentation and management of patients with type A acute aortic dissection (TAAAD). This report from the International Registry of Acute Aortic Dissection examines this hypothesis.
A total of 352 of 2196 patients with TAAAD (16%) enrolled in the International Registry of Acute Aortic Dissection had cardiac surgery before dissection, including coronary artery bypass grafting (34%), aortic or mitral valve surgery (36%), aortic surgery (42%), and other cardiac surgery (16%). Those with PCS were older, had a higher frequency of diabetes mellitus, hypertension, and atherosclerosis, and presented later from symptom onset to hospital presentation and diagnosis (all P<0.05). In-hospital mortality was significantly higher for PCS patients (34% versus 23%; P<0.001). Five-year mortality was independently predicted by PCS (hazard ratio [HR], 2.04; 95% confidence interval [CI], 1.05-3.95), age >70 years (HR, 2.65; 95% CI, 1.40-5.05), medical management (HR, 5.10; 95% CI, 2.43-10.71), distal communication (HR, 2.64; 95% CI, 1.35-5.14), and coma (HR, 9.50; 95% CI, 2.05-44.05). Among patients with PCS, in-hospital (43% medical versus 30% surgical; P=0.033) and intermediate-term mortality was higher in patients with medical versus surgical management. Propensity-matched analysis revealed significant increase in mortality with medical management, but not with PCS.
PCS delays presentation, diagnosis, and treatment of TAAAD and is an important adverse risk factor for early and intermediate-term mortality. This effect may be because of increased medical management in this patient population.
既往心脏手术(PCS)可使急性主动脉夹层 A 型(TAAAD)患者的临床表现和处理复杂化。本项来自急性主动脉夹层国际注册研究的报告对此假说进行了检验。
在国际急性主动脉夹层注册研究中,2196 例 TAAAD 患者中共有 352 例(16%)既往有心脏手术史,包括冠状动脉旁路移植术(34%)、主动脉瓣或二尖瓣手术(36%)、主动脉手术(42%)和其他心脏手术(16%)。既往有 PCS 的患者年龄更大,糖尿病、高血压和动脉粥样硬化更为常见,从症状发作到就诊和确诊的时间更晚(均 P<0.05)。PCS 患者院内死亡率显著更高(34%比 23%;P<0.001)。PCS 可独立预测 5 年死亡率(风险比[HR],2.04;95%置信区间[CI],1.05-3.95)、年龄>70 岁(HR,2.65;95% CI,1.40-5.05)、内科治疗(HR,5.10;95% CI,2.43-10.71)、远端交通(HR,2.64;95% CI,1.35-5.14)和昏迷(HR,9.50;95% CI,2.05-44.05)。在既往有 PCS 的患者中,内科治疗组的院内(43%比 30%;P=0.033)和中期死亡率更高,而外科治疗组无此差异。倾向评分匹配分析显示,内科治疗与死亡率显著增加相关,但与 PCS 无关。
PCS 可延迟 TAAAD 的表现、诊断和治疗,并且是早期和中期死亡率的重要不良风险因素。这种影响可能是由于此类患者人群中增加了内科治疗。